Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease
- PMID: 14579119
- DOI: 10.1007/s00415-003-1303-x
Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease
Abstract
Lewy bodies (LBs) are hallmark lesions in the brains of patients with Parkinson's disease (PD) and dementia with Lewy bodies (DLB). By raising a monoclonal antibody LB509 against purified LBs from the brains of patients with DLB that strongly immuola-beled LBs, we found that alpha-synuclein is one of the major components of LBs. Thus, the deposition of alpha-synuclein, an abundant presynaptic brain protein, as fibrillary aggregates in affected neurons or glial cells,was highlighted as a hallmark lesion of a subset of neurodegenerative disorders, including PD, DLB and multiple system atrophy collectively referred to as synucleinopathies. Importantly, the identification of missense mutations in alpha-synuclein gene in some pedigrees of familial PD has strongly implicated alpha-synuclein in the pathogenesis of PD and other synucleinopathies. We then examined the specific post-translational modifications that characterize and underlie the aggregation of alpha-synuclein in synucleinopathy brains by mass spectrometry and using a s pecific antibody,and found that serine 129 of alpha-synuclein deposited in synucleinopathy lesions is selectively and extensively phosphorylated. These findings underscore the importance of phosphorylation of filamentous proteins in the pathogenesis of neurodegenerative disorders.
Similar articles
-
alpha-Synuclein is phosphorylated in synucleinopathy lesions.Nat Cell Biol. 2002 Feb;4(2):160-4. doi: 10.1038/ncb748. Nat Cell Biol. 2002. PMID: 11813001
-
Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.Am J Pathol. 1998 Apr;152(4):879-84. Am J Pathol. 1998. PMID: 9546347 Free PMC article.
-
[Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].Rinsho Shinkeigaku. 1999 Dec;39(12):1285-6. Rinsho Shinkeigaku. 1999. PMID: 10791099 Japanese.
-
[The mechanism of Lewy body formation in Parkinson's disease].Nihon Rinsho. 2000 Oct;58(10):2022-7. Nihon Rinsho. 2000. PMID: 11068441 Review. Japanese.
-
Neuropathological spectrum of synucleinopathies.Mov Disord. 2003 Sep;18 Suppl 6:S2-12. doi: 10.1002/mds.10557. Mov Disord. 2003. PMID: 14502650 Review.
Cited by
-
The Nobel Path of Cellular Proteins.Mo Med. 2014 Mar-Apr;111(2):114-119. Mo Med. 2014. PMID: 30323516 Free PMC article.
-
Evaluation of Models of Parkinson's Disease.Front Neurosci. 2016 Jan 19;9:503. doi: 10.3389/fnins.2015.00503. eCollection 2015. Front Neurosci. 2016. PMID: 26834536 Free PMC article. Review.
-
_targeting ferroptosis with the lipoxygenase inhibitor PTC-041 as a therapeutic strategy for the treatment of Parkinson's disease.PLoS One. 2024 Sep 18;19(9):e0309893. doi: 10.1371/journal.pone.0309893. eCollection 2024. PLoS One. 2024. PMID: 39292705 Free PMC article.
-
Sentence processing in Lewy body spectrum disorder: the role of working memory.Brain Cogn. 2012 Mar;78(2):85-93. doi: 10.1016/j.bandc.2011.12.004. Epub 2012 Jan 2. Brain Cogn. 2012. PMID: 22218297 Free PMC article.
-
Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.Proc Natl Acad Sci U S A. 2004 Dec 14;101(50):17510-5. doi: 10.1073/pnas.0405313101. Epub 2004 Dec 2. Proc Natl Acad Sci U S A. 2004. PMID: 15576511 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous
